Swedish Pharmaceuticals & Biotech Profitable Climbers

Camurus

Market Cap: SEK 37.5b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Bonesupport Holding

Market Cap: SEK 15.0b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

BioArctic

Market Cap: SEK 29.9b

Develops biological drugs for patients with central nervous system disorders in Sweden.

Genovis AB (publ.)

Market Cap: SEK 1.3b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Devyser Diagnostics

Market Cap: SEK 1.0b

Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.

BioGaia

Market Cap: SEK 11.6b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

Swedencare

Market Cap: SEK 3.5b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

Swedish Orphan Biovitrum

Market Cap: SEK 160.2b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.